Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Publicis Group is expanding its network once again, this time with the acquisition of p-value Group — a full service medical communications group. The healthcare agency announced the acquisition ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

A review of p-values in the biomedical literature from 1990 to 2015 shows that these widely misunderstood statistics are being used increasingly, instead of better metrics of effect size or ...

If you cast a wide enough net, you’ll find what looks like a prize-winning fish. But you’ll also catch a lot of seaweed, plastic debris, and maybe even a dolphin you didn’t mean to bring in. Such is ...

For researchers there's a lot that turns on the p value, the number used to determine whether a result is statistically significant. The current consensus is that if p is less than .05, a study has ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a ...

How many ostensibly "positive" studies are wrong? In this deep-dive analysis, MedPage Today clinical reviewer F. Perry Wilson, MD, explains that the number may be much higher than you think. Some ...